Childrens Tussnex Multi-Symptom Cold

Description

Dextromethorphan HBr is a cough suppressant utilized for the relief of cough symptoms. Guaifenesin serves as an expectorant, effectively thinning and loosening mucus to facilitate easier expectoration. Phenylephrine HCl acts as a nasal decongestant, providing relief from nasal and chest congestion. This formulation is alcohol-free, ensuring a suitable option for various patient populations. The combination of these active ingredients works synergistically to soothe cough and alleviate congestion.

Uses and Indications

This drug is indicated for the relief of cough and nasal congestion associated with minor throat and bronchial irritation, which may occur due to colds or inhaled irritants. It helps to loosen phlegm (mucus) and thin bronchial secretions, facilitating drainage of the bronchial tubes and making coughs more productive.

The drug temporarily relieves the intensity of coughing and the impulse to cough, aiding in sleep for children experiencing these symptoms. Additionally, it alleviates nasal congestion and a stuffy nose associated with colds.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The maximum recommended dosage is 6 doses within a 24-hour period. It is imperative that the dosing cup provided with the product is used exclusively for measuring doses and not for any other products.

For dosing, the following guidelines should be adhered to, or as directed by a healthcare professional:

• For children aged 6 years to under 12 years, the recommended dose is 10 mL every 4 hours.

• For children aged 4 years to under 6 years, the recommended dose is 5 mL every 4 hours.

• The product is not recommended for use in children under 4 years of age.

Healthcare professionals should ensure that caregivers are informed of these dosing instructions to promote safe and effective use of the product.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the recommended dosage guidelines, as exceeding the directed use may lead to adverse effects.

Warnings and Precautions

The use of this product is contraindicated in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. Healthcare professionals should advise caregivers to consult a doctor or pharmacist if there is uncertainty regarding the presence of an MAOI in the child's prescription medication.

Before administering this product, it is essential to consult a healthcare provider if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, a persistent or chronic cough (such as that associated with asthma), or a cough accompanied by excessive phlegm (mucus). These conditions may necessitate additional monitoring or alternative treatment options.

In the event of an overdose, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

Caregivers should be instructed to discontinue use and consult a healthcare professional if the child experiences nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within seven days, or if they are accompanied by fever, or if a cough persists for more than seven days, recurs, or occurs with fever, rash, or a persistent headache, medical advice should be sought promptly, as these may indicate a more serious underlying condition.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience symptoms such as nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days, or if they are accompanied by fever, medical advice should be sought. A cough that persists for more than 7 days, recurs, or occurs alongside fever, rash, or a persistent headache may indicate a serious underlying condition and warrants immediate medical evaluation.

Drug Interactions

The concomitant use of this product with monoamine oxidase inhibitors (MAOIs) is contraindicated. This includes patients who are currently taking prescription MAOIs for conditions such as depression, psychiatric disorders, or Parkinson's disease, as well as those who have discontinued MAOI therapy within the preceding two weeks.

It is imperative that healthcare providers confirm whether a patient’s prescription includes an MAOI prior to administering this product. If there is any uncertainty regarding the presence of an MAOI in the patient's medication regimen, consultation with a physician or pharmacist is strongly advised to prevent potential adverse interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Tussnex Multi-Symptom Cold (dextromethorphan hbr, guaifenesin, phenylephrine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should not use this product if they are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of stopping such medication. Prior to use, it is essential to consult a healthcare professional if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as that associated with asthma), or cough accompanied by excessive phlegm.

Dosing recommendations for this product are as follows: for children aged 6 years to under 12 years, the dosage is 10 mL every 4 hours; for children aged 4 years to under 6 years, the dosage is 5 mL every 4 hours. This product is not recommended for children under 4 years of age.

While using this product, caregivers should ensure that the dosage is not exceeded. If the child experiences nervousness, dizziness, or sleeplessness, or if symptoms do not improve within 7 days, or if the cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache, the use of the product should be discontinued and a healthcare professional should be consulted.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Safety during pregnancy has not been established for this product. It is contraindicated in pregnancy unless directed by a healthcare provider. The potential risks to the fetus are not specified; therefore, it is essential for pregnant patients to consult their healthcare provider for personalized advice. No specific dosage modifications for pregnant individuals are provided, and healthcare providers should be consulted for recommendations tailored to the individual patient. Pregnant women are advised to seek medical advice before using this product to ensure safety for both themselves and their developing fetus.

Lactation

There are no specific warnings or recommendations regarding the use of this product by nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a poison control center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be aware that the specific symptoms of an overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential to determine the appropriate course of action.

Management of an overdose typically involves supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended. In cases where the specific substance is known, targeted therapies may be employed as indicated.

It is essential for healthcare providers to remain vigilant and act swiftly in the management of overdose situations to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: nervousness, dizziness, and sleeplessness. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. In the event of an overdose, patients should seek medical help or contact a poison control center immediately.

Patients should be instructed to stop using the product and consult a doctor if their child experiences nervousness, dizziness, or sleeplessness. Additionally, if symptoms do not improve within 7 days, or if they occur alongside fever, medical advice should be sought. It is also important to inform patients that a cough lasting more than 7 days, returning after resolution, or occurring with fever, rash, or persistent headache may indicate a serious illness, warranting further evaluation.

While using this product, patients must be reminded not to exceed the recommended dosage.

Healthcare providers should also encourage patients to consult a doctor before use if the child has any of the following conditions: heart disease, high blood pressure, thyroid disease, diabetes, a persistent or chronic cough such as that associated with asthma, or a cough accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied with a dosing cup included for accurate measurement. It should be stored at a temperature range of 15-30°C (59-86°F). It is important to note that refrigeration is not permitted, as the product must not be exposed to temperatures outside the specified range. Proper handling and storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Childrens Tussnex Multi-Symptom Cold, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)